Lecanemab Autoinjector 62856-0220
Generic: Lecanemab-Irmb
Product NDC
62856-0220- Manufacturer
- Eisai Inc.
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- August 29, 2025
- Listing Expires
- December 31, 2027
- Application
- BLA761375
Need to source Lecanemab Autoinjector? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lecanemab-Irmb | 200 mg/mL |
Drug Class
Amyloid Beta-directed Antibody [EPC]Amyloid Beta-directed Antibody Interactions [MoA]Amyloid Beta-directed Antibody [EPC]
Packaging Options(1)
1 SYRINGE, PLASTIC in 1 CARTON (62856-220-01) / 1.8 mL in 1 SYRINGE, PLASTIC (62856-220-10)